Last updated on December 2018

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of MT-5199 administered once daily for the treatment of Tardive Dyskinesia (TD) symptoms.

Clinical Study Identifier: NCT03176771

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Information Desk, to ...

Shiga University of Medical Science Hospital
Shiga, Japan
  Connect »

Clinical Trials Information Desk, to ...

Sagaarashiyama Tanaka Clinic
Kyoto, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.